{"count": 3, "results": [{"_id": "34246699", "pmid": 34246699, "title": "Metformin use and keratinocyte carcinoma risk.", "journal": "J Am Acad Dermatol", "authors": ["Misitzis A", "Weinstock MA"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.jaad.2021.04.105", "meta_date_publication": "2021 Oct", "meta_volume": "85", "meta_issue": "4", "meta_pages": "e263", "score": 50292.125, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use and @<m>DISEASE_Epidermal_Nevus</m> @DISEASE_MESH:C580062 @@@keratinocyte carcinoma@@@ risk.", "citations": {"NLM": "Misitzis A, Weinstock MA. Metformin use and keratinocyte carcinoma risk. J Am Acad Dermatol. 2021 Oct;85(4):e263. PMID: 34246699", "BibTeX": "@article{34246699, title={Metformin use and keratinocyte carcinoma risk.}, author={Misitzis A and Weinstock MA}, journal={J Am Acad Dermatol}, volume={85}, number={4}, pages={e263}}"}}, {"_id": "33047438", "pmid": 33047438, "title": "The association of metformin use with keratinocyte carcinoma development in high-risk patients.", "journal": "Dermatol Ther", "authors": ["Misitzis A", "Stratigos AJ", "Beatson M", "Mastorakos G", "Dellavalle RP", "Weinstock MA", "Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group"], "date": "2020-11-01T00:00:00Z", "doi": "10.1111/dth.14402", "meta_date_publication": "2020 Nov", "meta_volume": "33", "meta_issue": "6", "meta_pages": "e14402", "score": 50278.07, "text_hl": "The association of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use with @<m>DISEASE_Epidermal_Nevus</m> @DISEASE_MESH:C580062 @@@keratinocyte carcinoma@@@ development in high-risk @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Misitzis A, Stratigos AJ, Beatson M, Mastorakos G, Dellavalle RP, Weinstock MA, Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group. The association of metformin use with keratinocyte carcinoma development in high-risk patients. Dermatol Ther. 2020 Nov;33(6):e14402. PMID: 33047438", "BibTeX": "@article{33047438, title={The association of metformin use with keratinocyte carcinoma development in high-risk patients.}, author={Misitzis A and Stratigos AJ and Beatson M and Mastorakos G and Dellavalle RP and Weinstock MA and Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group}, journal={Dermatol Ther}, volume={33}, number={6}, pages={e14402}}"}}, {"_id": "35533029", "pmid": 35533029, "title": "Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma.", "journal": "J Drugs Dermatol", "authors": ["Misitzis A", "Stratigos A", "Mastorakos G", "Weinstock M"], "date": "2022-05-01T00:00:00Z", "doi": "10.36849/JDD.6087", "meta_date_publication": "2022 May 1", "meta_volume": "21", "meta_issue": "5", "meta_pages": "502-505", "score": 50274.934, "text_hl": "Previously we have demonstrated lower risk for a subsequent @<m>DISEASE_Epidermal_Nevus</m> @DISEASE_MESH:C580062 @@@KC@@@ in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Misitzis A, Stratigos A, Mastorakos G, Weinstock M. Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma. J Drugs Dermatol. 2022 May 1;21(5):502-505. PMID: 35533029", "BibTeX": "@article{35533029, title={Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma.}, author={Misitzis A and Stratigos A and Mastorakos G and Weinstock M}, journal={J Drugs Dermatol}, volume={21}, number={5}, pages={502-505}}"}}]}